These results could suggest that this mechanism may play a role in tumor initiation and progression related to BRCA1 loss of function, as cancer cells lacking this TSG could use this mechanism to escape the host’s anti-tumor immune surveillance mechanisms. The gene discussed is BRCA1; the disease is neoplasm.